SCHEMBL20139699

SCHEMBL20139699

C=CCOc1ccc(Br)cc1C(O)c1ccc2c(c1)CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
HTT P42858 1/20 0.39
ADRA2A P08913 3/20 0.38
ADRA2B P18089 3/20 0.38
ADRA2C P18825 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 2/20 0.34
TSHR P16473 2/20 0.34
HSP90AA1 P07900 1/20 0.33
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
RAB9A P51151 1/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20140072 0.80 KMT2A (0.40) HPGDALDH1A1KMT2AADRA2ATDP1
SCHEMBL20139642 0.78 HTR2A (0.37) HPGDADRA2AADRA2BADRA2CSMN1; SMN2
SCHEMBL20139400 0.72 KMT2A (0.42) ALDH1A1KMT2AMEN1HTTTDP1
SCHEMBL20139416 0.72 ALDH1A1 (0.39) ALDH1A1KMT2AHTTTDP1GAA
SCHEMBL20139451 0.72 KMT2A (0.42) ALDH1A1KMT2AMEN1HTTSMN1; SMN2
SCHEMBL20139425 0.72 MEN1 (0.50) HPGDALDH1A1MAPK1KMT2AMEN1
SCHEMBL20139705 0.69 ALDH1A1 (0.40) ALDH1A1KMT2AHTTGAAHSP90AA1
SCHEMBL5699674 0.68 ALDH1A1 (0.41) HPGDALDH1A1MAPK1KMT2AMEN1
SCHEMBL24353756 0.68 MAPT (0.46) HPGDMAPK1MAPTGAATSHR
SCHEMBL7143238 0.67 HPGD (0.69) HPGDALDH1A1MAPK1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10815210-B2 Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators JANSSEN PHARMACEUTICA NV (BE) 2020-10-27 US disclosed
WO-2018089449-A1 BENZOCYCLOBUTANE DERIVATIVES USEFUL AS DUAL SGLT1/SGLT2 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10815210-B2 Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators SLC5A2, SLC5A1, SLC2A2 HPGD 1858/4885ALDH1A1 2392/4885MAPK1 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.